SCHEMBL24405997

SCHEMBL24405997

CN(C)c1ccc(N(C)C)c(-n2c(=O)n(C)c3ccccc32)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.39
▸ ALDH1A1 P00352 6/20 0.38
▸ HPGD P15428 5/20 0.38
▸ KDM4E B2RXH2 5/20 0.38
▸ HSD17B10 Q99714 4/20 0.38
▸ NPSR1 Q6W5P4 2/20 0.38
▸ THRB P10828 1/20 0.38
▸ P2RX4 Q99571 1/20 0.37
▸ BRPF1 P55201 2/20 0.37
▸ BRD1 O95696 1/20 0.37
▸ TAF1 P21675 1/20 0.37
▸ PGR P06401 1/20 0.37
▸ LMNA P02545 3/20 0.36
▸ ALOX15 P16050 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ GLA P06280 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ RAB9A P51151 4/20 0.35
▸ NPC1 O15118 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24405804 0.81 CYP1A2 (0.40) MAPTALDH1A1HPGDKDM4EHSD17B10
SCHEMBL13376862 0.68 PGR (0.64) MAPTALDH1A1HPGDKDM4EHSD17B10
SCHEMBL24405665 0.67 TP53 (0.53) MAPTALDH1A1KDM4ENPSR1BRPF1
SCHEMBL29798837 0.66 CYP1A2 (0.55) ALDH1A1KDM4EHSD17B10BRPF1PGR
SCHEMBL474339 0.66 CYP1A2 (0.55) ALDH1A1KDM4EHSD17B10BRPF1PGR
SCHEMBL6362809 0.66 PGR (0.68) ALDH1A1KDM4EPGRLMNASMN1; SMN2
SCHEMBL24405984 0.65 EED (0.45) MAPTPGRGAARAB9ANPC1
SCHEMBL30402458 0.65 GRM4 (0.45) MAPTALDH1A1KDM4EPGRLMNA
SCHEMBL24405919 0.64 CYP1A2 (0.47) MAPTALDH1A1KDM4EPGRKMT2A
SCHEMBL21173494 0.64 ALDH1A1 (0.53) MAPTALDH1A1HPGDKDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3774739-B1 FUSED CYCLIC UREA DERIVATIVES AS CRHR2 ANTAGONIST RAQUALIA PHARMA INC (JP) 2022-05-11 — — EP disclosed
Send feedback